Weybosset Research & Management’s MaxLinear MXL Stock Holding History

Weybosset Research & Management’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-205,893	Closed	-$3.31M	–	36
2025 Q3	$3.31M	Sell	205,893 -72,801	-26%	-$1.14M	1.07%	23
2025 Q2	$3.96M	Buy	278,694 +61,723	+28%	+$712K	1.36%	22
2025 Q1	$2.36M	Buy	216,971 +124,240	+134%	+$2.08M	0.82%	24
2024 Q4	$1.83M	Buy	92,731 +23,576	+34%	+$378K	0.62%	25
2024 Q3	$1M	Buy	69,155 +45,457	+192%	+$722K	0.34%	25
2024 Q2	$477K	Buy	+23,698	New	+$466K	0.18%	27

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Weybosset Research & Management's MXL Position: Q4 2025 in Review

Weybosset Research & Management sold out of MaxLinear (MXL) in Q4 2025, closing a stake of 205,893 shares — an estimated $3.31M sold.

Weybosset Research & Management first reported a position in MXL in Q2 2024 and held it in 6 quarters. The position peaked at $3.96M in Q2 2025. 240 funds tracked by Wall St. Rank hold MXL as of Q4 2025.

Weybosset Research & Management reported no remaining MaxLinear position as of Q4 2025 after selling out during the quarter.
Weybosset Research & Management sold 205,893 MaxLinear shares in Q4 2025, an estimated $3.31M.
Weybosset Research & Management first reported a position in MaxLinear in Q2 2024 and held it in 6 quarters.
Weybosset Research & Management's MaxLinear position peaked at $3.96M in Q2 2025.
240 funds tracked by Wall St. Rank held MaxLinear as of Q4 2025.

Based on Weybosset Research & Management's 13F filing for Q4 2025, filed 6 Jan 2026.